Finally, circulating molecules, such as ADMA, galectin-3, ghrelin, MiRNAs and auto-antibodies can be detected and quantified in PAH patients and could serve as biomarkers for disease diagnosis, severity, and progression. Here, GHRL is linked to pulmonary arterial hypertension.